-
- 抗原 See all DRAK2 (STK17B) 抗体
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
抗原表位
- Internal Region
-
适用
- 人, 犬
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This DRAK2 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 序列
- C-HSVRSSEDKT SK
- 特异性
- This antibody detects STK17B / DRAK2 (Internal).
- 交叉反应 （详细）
- Species reactivity (expected):DogSpecies reactivity (tested):Human
- 纯化方法
- Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
- 免疫原
- Peptide from the internal region of the protein sequence according to NP_004217.1
- Top Product
- Discover our top product STK17B Primary Antibody
-
anti-serine/threonine Kinase 17b (STK17B) (AA 272-372) antibody
STK17B 适用: 人 ELISA, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal 2C3 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 342-371), (C-Term) antibodySTK17B 适用: 人, 小鼠 WB, IF, IHC (p) 宿主: 兔 Polyclonal RB3049 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 235-366) antibodySTK17B 适用: 人 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 1-372) antibodySTK17B 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, WB, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodyVerified STK17B 适用: 人 ELISA, WB 宿主: 山羊 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Center) antibodySTK17B 适用: 人, 小鼠, 大鼠, Cow WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B 适用: 人 WB, IF, EIA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Peptide ELISA: antibody detection limit dilution 1: 32000. Western blot: 1-3 μg/mL. Approx 45 kDa band observed in lysates of cell line MOLT4(calculated MW of 42.5 kDa according to NP_004217.1).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - 限制
- 仅限研究用
-
- 浓度
- 0.5 mg/mL
- 缓冲液
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2 - 8 °C up to one week or (in aliquots) at -20 °C for longer.
-
- 抗原
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- 别名
- STK17B / DRAK2 (STK17B 产品)
- 别名
- zgc:65989 antibody, STK17B antibody, DRAK2 antibody, Drak2 antibody, 3110009A03Rik antibody, AI120141 antibody, serine/threonine kinase 17b (apoptosis-inducing) antibody, serine/threonine kinase 17b antibody, stk17b antibody, STK17B antibody, Stk17b antibody
- 背景
- Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases). DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues. Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP,are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase-related apoptosis-inducing protein kinases) (1). DRAKs contain anN-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.Synonyms: DAP kinase-related apoptosis-inducing protein kinase 2, Serine/threonine-protein kinase 17B
- 基因ID
- 9262
- NCBI登录号
- NP_004217
- UniProt
- O94768
-
You are here:
